Back to Trades
Schimmelpennink Evert B.
DirectorCIK 0001713795
Profile
- Filings
- 4
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
Schimmelpennink Evert B., Director, accounts for 4 disclosed filings worth $6.3M, spread across 3 companies, active 2025–2026. The record is heavily weighted toward buying, with $251.4K in purchases against $0 in sales. The largest single open-market purchase on record is $251.4K in LENZ Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jun 26 | CTNM Contineum Therapeutics, Inc. | Schimmelpennink Evert B. | Director | Award | $269.6K |
| Mar 30 | LENZ LENZ Therapeutics, Inc. | Schimmelpennink Evert B. | President, CEO and Secretary, Director | Buy | $251.4K |
| Jan 6 | LENZ LENZ Therapeutics, Inc. | Schimmelpennink Evert B. | President, CEO and Secretary, Director | Award | $5.7M |
| Nov 24 | IBIO iBio, Inc. | Schimmelpennink Evert B. | Director | Award | $13.5K |
4 filings